Captagon

A synthetic amphetamine produced and exported by the Assad regime and its affiliated militias, generating billions of dollars annually from Gulf markets. By the early 2020s it had become one of the Syrian state’s primary revenue sources.

Captagon — originally a brand name for the pharmaceutical fenethylline, banned in most countries since the 1980s — refers in contemporary usage to a cheaply produced amphetamine tablet manufactured at industrial scale in regime-controlled Syria. Production began accelerating around 2016 as the Syrian economy collapsed under war and sanctions, and by 2020 Syria had become the world’s largest producer. The trade was controlled not by independent criminal networks but by military units and regime-connected businessmen, most prominently figures linked to the Fourth Armoured Division under Maher al-Assad, Bashar’s brother. Export routes ran through Lebanon, Jordan, and Gulf ports, with Saudi Arabia emerging as the largest market. UN experts estimated the trade at several billion dollars annually by 2021 — in a formal economy the Caesar Act had reduced to near-collapse, this revenue was existential for regime survival. The trade also served a political function: it compromised border officials, customs officers, and politicians across the region, creating networks of dependency and complicity that gave Damascus leverage far beyond its military reach.

Captagon is the clearest evidence that the Assad regime had by the 2020s ceased to function as a state in any meaningful sense and had become a criminal enterprise using state power as its enforcement mechanism. A government that sustains itself by flooding neighbouring countries with amphetamines — creating addiction, financing corruption, and profiting from the social destruction it causes — has abandoned any claim to legitimate sovereignty. The regional response was instructive: several Arab governments moved toward normalising relations with Damascus in 2023 partly on the calculation that engagement might reduce the drug flows, tacitly acknowledging that they lacked the leverage to stop them otherwise. This normalisation strategy had largely failed by the time Assad fell in December 2024, but it illustrated how comprehensively the drug trade had distorted the region’s diplomatic calculations.